Skip to main content
Veterinary Medicines

Acticam 2.5 mg chewable tablets for Dogs

Not authorised
  • Meloxicam

Product identification

Medicine name:
Acticam 2.5 mg chewable tablets for Dogs
Acticam 2,5 mg Comprimidos mastigáveis para cães
Active substance:
  • Meloxicam
Target species:
  • Dog
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Meloxicam
    2.50
    milligram(s)
    /
    1.00
    Tablet
Pharmaceutical form:
  • Chewable tablet
Withdrawal period by route of administration:
  • Oral use
    • Dog
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QM01AC06
Authorisation status:
  • Revoked
Authorised in:
  • Portugal
Package description:
  • 100 tablets (10x10) in a carton box. PVC/PVDC-Alu blister pack made of clear PVC/PVDC and Plain Alu foil. Each blister has 10 tablets.
  • 500 tablets (10x50) in a carton box. PVC/PVDC-Alu blister pack made of clear PVC/PVDC and Plain Alu foil. Each blister has 10 tablets.
  • 20 tablets (10x2) in a carton box. PVC/PVDC-Alu blister pack made of clear PVC/PVDC and Plain Alu foil. Each blister has 10 tablets.
  • 10 tablets (10x1) in a carton box. PVC/PVDC-Alu blister pack made of clear PVC/PVDC and Plain Alu foil. Each blister has 10 tablets.

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Ecuphar
Marketing authorisation date:
Manufacturing sites for batch release:
  • Accord Healthcare Limited
Responsible authority:
  • Directorate General For Food And Veterinary
Authorisation number:
  • 312/02/11DFVPT
Date of authorisation status change:
Reference member state:
  • Netherlands
Procedure number:
  • NL/V/0134/002

Documents

Combined File of all Documents

This document does not exist in this language (English). You can find it in another language below.
Portuguese (PDF)
Published on: 17/10/2024
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."